Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons S.Y. (Sanne) Smith-Apeldoorn

Publicaties

Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study

Oral Esketamine as Alternative for Maintenance Electroconvulsive Therapy in Patients with Treatment-Resistant Depression: A Case Series

Oral esketamine for difficult-to-treat depression

Plasma esketamine and noresketamine levels and antidepressant response with oral esketamine treatment

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension

Correction to: Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study

Safety of Ketamine Augmentation to Monoamine Oxidase Inhibitors in Treatment-Resistant Depression: A Systematic Literature Review and Case Series

Pers/media

‘Geef selecte groep depressiepatiënten langdurig ketamine’

‘Geef selecte groep depressiepatiënten langdurig ketamine’